Julie Decock

3.3k total citations
49 papers, 2.0k citations indexed

About

Julie Decock is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Julie Decock has authored 49 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 26 papers in Cancer Research and 17 papers in Molecular Biology. Recurrent topics in Julie Decock's work include Protease and Inhibitor Mechanisms (20 papers), Peptidase Inhibition and Analysis (11 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Julie Decock is often cited by papers focused on Protease and Inhibitor Mechanisms (20 papers), Peptidase Inhibition and Analysis (11 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Julie Decock collaborates with scholars based in Qatar, United Kingdom and Belgium. Julie Decock's co-authors include Wouter Hendrickx, Remy Thomas, Adviti Naik, Dylan R. Edwards, Davide Bedognetti, Jessica Roelands, Robert Paridaens, Sally Thirkettle, Eyad Elkord and Salman M. Toor and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Julie Decock

49 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julie Decock Qatar	23	1.1k	761	659	613	229	49	2.0k
Daisuke Uchida Japan	25	1.2k 1.1×	1.2k 1.5×	676 1.0×	741 1.2×	182 0.8×	84	2.7k
Slawomir Wojtowicz‐Praga United States	14	738 0.7×	675 0.9×	560 0.8×	358 0.6×	135 0.6×	20	1.6k
Hernan Roca United States	21	850 0.8×	1.2k 1.6×	350 0.5×	779 1.3×	222 1.0×	39	2.5k
Gabriel Wong United States	14	764 0.7×	1.3k 1.7×	519 0.8×	481 0.8×	150 0.7×	17	2.1k
Ines Gütgemann Germany	25	1.1k 1.1×	1.3k 1.7×	368 0.6×	1.2k 1.9×	332 1.4×	60	3.0k
Praveen Bhoopathi United States	27	628 0.6×	964 1.3×	500 0.8×	403 0.7×	130 0.6×	52	1.9k
Katarzyna Miękus Poland	19	609 0.6×	1.8k 2.4×	999 1.5×	443 0.7×	254 1.1×	37	2.7k
Huaxiang Xu China	23	1.0k 1.0×	735 1.0×	477 0.7×	662 1.1×	281 1.2×	54	2.1k
Carter Van Waes United States	18	647 0.6×	821 1.1×	408 0.6×	321 0.5×	147 0.6×	28	1.5k
Eliza Wiercinska Germany	22	788 0.8×	1.1k 1.4×	316 0.5×	263 0.4×	194 0.8×	41	2.1k

Countries citing papers authored by Julie Decock

Since Specialization

Citations

This map shows the geographic impact of Julie Decock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Decock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Decock more than expected).

Fields of papers citing papers by Julie Decock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Decock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Decock. The network helps show where Julie Decock may publish in the future.

Co-authorship network of co-authors of Julie Decock

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Decock. A scholar is included among the top collaborators of Julie Decock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Decock. Julie Decock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Naik, Adviti, et al.. (2025). Immunomodulatory effects of tumor Lactate Dehydrogenase C (LDHC) in breast cancer. Cell Communication and Signaling. 23(1). 145–145. 2 indexed citations

Naik, Adviti, et al.. (2024). The LDHC-STAT3 Signaling Network Is a Key Regulator of Basal-like Breast Cancer Cell Survival. Cancers. 16(13). 2451–2451. 1 indexed citations

Ponirakis, Georgios, Aijaz Parray, Marwan Ramadan, et al.. (2024). Untargeted Metabolomic Profiling Reveals Differentially Expressed Serum Metabolites and Pathways in Type 2 Diabetes Patients with and without Cognitive Decline: A Cross-Sectional Study. International Journal of Molecular Sciences. 25(4). 2247–2247. 4 indexed citations

Naik, Adviti, et al.. (2024). Cancer testis antigens: Emerging therapeutic targets leveraging genomic instability in cancer. SHILAP Revista de lepidopterología. 32(1). 200768–200768. 7 indexed citations

Abdesselem, Houari, Mohamed M. Emara, Nehad M. Alajez, et al.. (2023). Blood Proteomics Analysis Reveals Potential Biomarkers and Convergent Dysregulated Pathways in Autism Spectrum Disorder: A Pilot Study. International Journal of Molecular Sciences. 24(8). 7443–7443. 4 indexed citations

Elango, Ramesh, Sameera Rashid, Radhakrishnan Vishnubalaji, et al.. (2023). Transcriptome profiling and network enrichment analyses identify subtype-specific therapeutic gene targets for breast cancer and their microRNA regulatory networks. Cell Death and Disease. 14(7). 415–415. 8 indexed citations

Mall, Raghvendra, Adviti Naik, Remy Thomas, et al.. (2022). Immune-related 3-lncRNA signature with prognostic connotation in a multi-cancer setting. Journal of Translational Medicine. 20(1). 442–442. 7 indexed citations

Naik, Adviti & Julie Decock. (2021). Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy. Molecular Oncology. 16(4). 885–903. 19 indexed citations

Naik, Adviti, et al.. (2021). Cancer testis antigen PRAME: An anti‐cancer target with immunomodulatory potential. Journal of Cellular and Molecular Medicine. 25(22). 10376–10388. 25 indexed citations

10.

Roelands, Jessica, Raghvendra Mall, Remy Thomas, et al.. (2021). Ancestry-associated transcriptomic profiles of breast cancer in patients of African, Arab, and European ancestry. npj Breast Cancer. 7(1). 10–10. 21 indexed citations

11.

Thomas, Remy, Hibah Shaath, Adviti Naik, et al.. (2020). Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy. Cancer Immunology Immunotherapy. 69(3). 449–463. 22 indexed citations

12.

Naik, Adviti, et al.. (2019). PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer. Journal of Translational Medicine. 17(1). 9–9. 51 indexed citations

13.

Decock, Julie, et al.. (2019). Cancer Testis Antigens and Immunotherapy: Where Do We Stand in the Targeting of PRAME?. Cancers. 11(7). 984–984. 84 indexed citations

14.

Sarper, Müge, Michael D. Allen, Julie Decock, et al.. (2017). Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function. Breast Cancer Research. 19(1). 33–33. 30 indexed citations

15.

Roelands, Jessica, Peter J.K. Kuppen, Louis Vermeulen, et al.. (2017). Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications. International Journal of Molecular Sciences. 18(10). 2229–2229. 105 indexed citations

16.

Kelwick, Richard, Laura Wagstaff, Julie Decock, et al.. (2014). Metalloproteinase‐dependent and ‐independent processes contribute to inhibition of breast cancer cell migration, angiogenesis and liver metastasis by a disintegrin and metalloproteinase with thrombospondin motifs‐15. International Journal of Cancer. 136(4). E14–26. 44 indexed citations

17.

Decock, Julie, Sally Thirkettle, Laura Wagstaff, & Dylan R. Edwards. (2011). Matrix metalloproteinases: protective roles in cancer. Journal of Cellular and Molecular Medicine. 15(6). 1254–1265. 150 indexed citations

18.

Decock, Julie, Wouter Hendrickx, Ulla Vanleeuw, et al.. (2008). Plasma MMP1 and MMP8 expression in breast cancer: Protective role of MMP8 against lymph node metastasis. BMC Cancer. 8(1). 77–77. 65 indexed citations

19.

Decock, Julie, Jirong Long, Ross C. Laxton, et al.. (2007). Association of Matrix Metalloproteinase-8 Gene Variation with Breast Cancer Prognosis. Cancer Research. 67(21). 10214–10221. 79 indexed citations

20.

Decock, Julie, Wouter Hendrickx, Hans Wildiers, et al.. (2005). Plasma Gelatinase Levels in Patients with Primary Breast Cancer in Relation to Axillary Lymph Node Status, Her2/neu Expression and other Clinicopathological Variables. Clinical & Experimental Metastasis. 22(6). 495–502. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact